Asia Pacific Diabetes Devices Market Size & Outlook
Asia Pacific diabetes devices market, 2018-2030 (US$M)
Related Markets
Asia Pacific diabetes devices market highlights
- The Asia Pacific diabetes devices market generated a revenue of USD 6,487.3 million in 2023.
- The market is expected to grow at a CAGR of 9% from 2024 to 2030.
- In terms of segment, insulin delivery devices was the largest revenue generating type in 2023.
- Insulin Delivery Devices is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Japan is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 6,487.3 million |
| Market revenue in 2030 | USD 11,876.5 million |
| Growth rate | 9% (CAGR from 2023 to 2030) |
| Largest segment | Insulin delivery devices |
| Fastest growing segment | Insulin Delivery Devices |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Blood Glucose Monitoring (BGM) Devices, Insulin Delivery Devices |
| Key market players worldwide | Medtronic PLC, Abbott Laboratories, Roche Holding AG, Bayer AG, Johnson & Johnson, B. Braun, DexCom Inc, Insulet Corp, Ypsomed Holding AG, Sanofi SA, Novo Nordisk A/S ADR, Arkray |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 21.4% of the global diabetes devices market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 11,876.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Diabetes Devices Market Scope
Diabetes Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific diabetes devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetes devices market will help companies and investors design strategic landscapes.
Insulin delivery devices was the largest segment with a revenue share of 54.19% in 2023. Horizon Databook has segmented the Asia Pacific diabetes devices market based on blood glucose monitoring (bgm) devices, insulin delivery devices covering the revenue growth of each sub-segment from 2018 to 2030.
The Asia Pacific region is majorly driven by China and Japan. China dominated the overall diabetes devices market in the region in terms of revenue share. This can be attributed to presence of major market players and increasing prevalence of diabetes.
In addition, technological advancements in blood glucose monitoring devices, increasing geriatric population, and growing prevalence of lifestyle diseases, such as obesity, are among factors anticipated to promote growth of blood glucose monitoring devices market.
However, under-diagnosis is common in many Low and Middle-Income Countries (LMIC), and traditional blood glucose testing methods are still used in these countries over continuous glucose monitoring due to lack of awareness and high equipment costs.
Reasons to subscribe to Asia Pacific diabetes devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific diabetes devices market databook
-
Our clientele includes a mix of diabetes devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific diabetes devices market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific diabetes devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific diabetes devices market size, by country, 2018-2030 (US$M)
Asia Pacific Diabetes Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
